治疗前与近距离治疗前MRI一阶放射组学特征联合临床因素预测宫颈癌放化疗预后
本研究纳入100例局部晚期宫颈癌患者,接受根治性同步放化疗(IMRT/VMAT)后三维腔内近距离治疗,从治疗前和近距离治疗前T2WI与DWI图像提取原发肿瘤和淋巴结的一阶放射组学特征。多变量Cox回归显示,临床因素联合放射组学特征(CF+RF)模型在PFS、LRFS、DMFS和OS的预测中Harrell's C-index最高。
要点
- 治疗前和近距离治疗前的一阶放射组学特征可增加临床因素对CCRT后结局的预测价值。
- CF+RF联合模型在全部临床结局中C-index均高于单独CF或RF模型。
- 治疗前和近距离治疗前模型C-index高于两者差值(Diff)模型。
核心结论
- 一阶放射组学特征联合临床因素可提高对宫颈癌CCRT后PFS、LRFS、DMFS和OS的预测性能。
- 治疗前和近距离治疗前联合临床与放射组学特征的模型预测性能最高。
研究设计与样本
- 研究纳入100例局部晚期宫颈癌患者,均接受根治性同步放化疗(IMRT/VMAT)后三维腔内近距离治疗。
- 基于治疗前和近距离治疗前T2WI与DWI图像勾画原发肿瘤(GTVp)和淋巴结(GTVn),导入MIM软件提取一阶放射组学特征。
- 采用单变量和多变量Cox回归分析放射组学值与临床因素,构建PFS、LRFS、DMFS和OS预测模型并评估乐观指数和校准图。
主要发现
- 中位随访时间24.5个月,2年PFS、LRFS、DMFS和OS率分别为71%、88.6%、83.1%和83.5%。
- 对于所有临床结局,治疗前和近距离治疗前的CF+RF联合模型Harrell's C-index均高于单独CF或RF模型。
- 治疗前和近距离治疗前模型的Harrell's C-index高于Diff模型。
- 治疗前和近距离治疗前CF+RF模型对PFS、LRFS、DMFS和OS的C-index分别为0.739、0.873、0.830和0.967,乐观指数分别为0.312、0.381、0.316和0.242。
临床怎么用
- 利用商业软件提取治疗前和近距离治疗前MRI一阶放射组学特征,可辅助临床因素进行宫颈癌CCRT后生存预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
MATERIALS AND METHODS: The study included 100 patients with LACC who underwent definitive CCRT with IMRT/VMAT technique followed by 3D-IGABT. MRI-based contouring included T2WI and DWI images for primary tumor (GTVp) and lymph nodes (GTVn). The contours were imported to MIM software to extract first-order radiomic features. Radiomic values from pre-treatment (PreRx), pre-brachytherapy (PreBT), differences between PreRx and PreBT (Diff) radiomic and clinical factors were analyzed using univariate and multivariate Cox regression analysis. Predictive models of PFS, LRFS, DMFS, and OS were created along with the optimism index and calibration plot. RESULTS: The median follow-up time was 24.5 months. The 2-year of PFS, LRFS, DMFS, and OS rates were 71, 88.6, 83.1, and 83.5 %, respectively. For all clinical outcomes, CF + RF combined from PreRx and PreBT resulted in the highest Harrell's C-index compared with the CF or RF alone. Compare with Diff models, models from PreRx and PreBT resulted in higher Harrell's C-index. The C-indexes from the CF + RF model from PreRx and PreBT for PFS, LRFS, DMFS, and OS were 0.739, 0.873, 0.830 and 0.967 with the optimism indexes of 0.312, 0.381, 0.316, and 0.242, respectively. CONCLUSION: Radiomic features from the first-order statistics added values to clinical factors to predict the outcomes after CCRT. The highest prediction model performance was for the combined clinical and radiomics from PreRx and PreBT.
引用
- Sittiwong W, Dankulchai P, Wongsuwan P, et al. Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives. Clin Transl Radiat Oncol. 2025. PMID: 40331124. doi:10.1016/j.ctro.2025.100965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。